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Background: Birth defects are disproportionately higher among certain race/ethnic groups. 
We examined how birth defects prevalence differs among the less studied non-Hispanic (NH) 
Asian and any American Indian/Alaska Native (AI/AN) populations, relative to NH Whites.  
Methods: Data were obtained from the Texas Birth Defect Registry from 1999 to 2015 for 
infants born to Texas-resident mothers who were NH White, NH Asian, or AI/AN. This 
covers a livebirth population of 2.6 million. Prevalence ratios were calculated for NH Asians 
and AI/ANs (relative to NH Whites) for 44 birth defects using Poisson regression and were 
adjusted for maternal age. 
Results: After adjustment, there were 34 statistically significant prevalence ratios. Among 
NH Asians, 23 defects had a lower adjusted prevalence ratio (aPR) and 3 defects had a higher 
aPR. AI/ANs had 2 defects with a significantly lower aPR and 6 with a higher aPR. 
Conclusions: NH Asians generally have a lower prevalence for birth defects while AI/ANs 
have a higher prevalence compared to NH Whites. These findings update the limited 
previous literature on this topic and also warrant additional research among larger 
populations in order to identify the true association of these understudied race/ethnic groups. 
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BACKGROUND 
Literature Review 
In the United States (U.S.), birth defects affect 1 in every 33, or 3.0%, of all live 
births.1 Birth defects are common and are the leading cause of infant mortality. In 2016, the 
Centers for Disease Control and Prevention (CDC) reported that birth defects accounted for 
20.8% off all infant deaths.3 Infant mortality can be used as a predictor of overall health in a 
given population. As birth defects are the number one cause of infant death in the U.S., it is 
important to better understand the underlying causes, risk factors for, and strategies for 
preventing them. 
In Texas, the overall prevalence of birth defects is 4.7%, which is higher compared to 
the national percent prevalence.2 The infant mortality rate in the U.S. as a whole is 5.9 per 
1,000 live births.3 Among the 50 states in the U.S., Texas has the 32nd highest infant 
mortality rate— with a rate of 5.7 per 1,000 live births.4 These statistics provide evidence 
that Texas measures similarly to nationwide values. Consequently, studies of birth defects in 
Texas may be helpful in providing a framework for developing future studies incorporating 
data from other regions of the U.S. 
Birth defects are disproportionally associated with specific racial/ethnic groups. One 
of the most commonly studied associations is the increased prevalence of neural tube defects 
(NTDs) among Hispanics.5 Further, race/ethnicity groups often examined in birth defect 
analyses are typically limited to non-Hispanic (NH) Whites, NH Blacks, and Hispanics.6-9  
Minority groups such as Asians and American Indians/Alaska Natives (AI/ANs) generally 
make up a small proportion of the population in comparison to other race/ethnicity groups, 
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making it difficult to conduct meaningful subgroup analyses. Researchers, therefore, have 
frequently ignored these groups or lumped them into an “Other” category to increase sample 
size and power. When this is done, however, important differences with respect to culture, 
environment, and genetic makeup are missed. Cultural and environmental differences 
between race/ethnicity groups point to potential differences in socioeconomic status— a 
factor also associated with varying environmental exposures, access to care issues, low 
maternal educational attainment, and barriers to services.10  
In addition to cultural and environmental factors, genetics also play a role in birth 
defect outcomes. Research on birth defects and genetics, however, is incomplete due to its 
complex nature.11 Various studies have shown that individuals with similar biogeographical 
ancestry, which can be categorized broadly by race/ethnicity, have a similar genetic 
makeup.12 Therefore, it is important to examine specific groupings rather than the more 
homogeneous “Other” category, to fully elucidate these differences.   
According to data from the U.S. Census Bureau, Asians were the fastest growing 
racial/ethnic group in the U.S. during the period of 2000 to 2010, increasing 43% during this 
time.13   Similarly, the AI/AN population also experienced a 39% growth.14  Although these 
two populations are among the fastest growing in the U.S., little is known about the 
occurrence and etiology of birth defects with reference to these groups.  
In a previous study using pooled data from 12 population-based state birth defects 
surveillance systems in the U.S., Canfield et al. (2014), provided prevalence data for selected 
birth defects among 5 racial/ethnic groups, including Asians and AI/AN.15 Analyses were 
conducted for infants born from 1999 to 2007. Results of this study showed a higher 
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prevalence for selected birth defects for AI/ANs and a lower prevalence among Asians. 
Marengo et al. (2018) further studied birth defect prevalence in the AI/AN population 
incorporating additional covariates.16 The results of this study showed that higher prevalence 
remained for two birth defects even after adjustment. To build on these findings, the present 
study included more recent data for analyses from 1999 through 2015 birth year in Texas, 
and considered an important covariate, maternal age. Currently, there are no studies on the 
prevalence of birth defects among Asian and AI/AN race/ethnicity groups for this extended 
period in Texas, including data from recent years.   
 
Public Health Significance 
Infant mortality can be used as a proxy for a nation’s health and is a commonly used 
proxy measure worldwide.17 This measure is highly regarded because there are many 
contributing factors including those related to maternal health, access to care, socioeconomic 
factors, and environmental health. In a report conducted by MacDorman et al. (2010), the 
U.S. ranked 26th out of the 29 European countries in the Organisation for Economic Co-
operation and Development (OECD) database.17  Although a developed country, the U.S. 
ranks behind many developing nations. In order to reduce the nation’s infant mortality rate, it 
is important to recognize that birth defects are the most common cause of infant mortality in 
the U.S. 
While birth defects as a whole are somewhat common occurrences, individual birth 
defects can be quite rare. Moreover, each birth defect has its own unique etiology and 
mortality profile. Since there is high variation from one defect to another, the causes are 
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largely unknown. Feldkamp et al. (2017), conducted a five-year population-based study to 
assess the causes of birth defects that are monitored in Utah’s birth defect surveillance 
system.18 The results showed that only 20% of birth defects had a known etiology, 
underscoring the fact that there are large gaps in the literature regarding birth defects. In 
order to create effective interventions to reduce the largest contributor to infant mortality, it 
is important to first understand what causes birth defects and their associated risk factors. 
Thus the specific aims of this research are: 
 
Specific Aims 
1. To describe the prevalence of 44 selected birth defects among non-Hispanic (NH) 
Whites, NH Asians, and American Indians/Alaskan Natives (AI/ANs) in Texas from 
1999 to 2015. 
2. To determine the unadjusted associations between NH Asian or AI/AN (regardless of 
Hispanic ethnicity) and selected birth defects, relative to NH Whites. 
3. To describe the relationship between NH Asians or AI/ANs and selected birth 
defects, relative to NH Whites, with adjustment for maternal age. 
 
METHODS 
Dataset 
In this study we used data from the Texas Birth Defects Registry (BDR). The Texas 
BDR is an active surveillance system that is population-based and maintained by Texas 
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Department of State Health Services (DSHS) Birth Defects Epidemiology and Surveillance 
(BDES) Branch. Statewide data became available in the Texas BDR in 1999 and includes 
complete data up to 2015. This study included complete data on infants born from 1999 to 
2015 (regardless of pregnancy outcome) and whose mothers were residents of Texas at the 
time of delivery. Data used in this analysis were de-identified line-item data for both birth 
defects and birth records.  
 
Outcome 
Infants included in the study were diagnosed with at least one or more of 44 selected 
birth defects within the first year of life. The birth defects considered for analyses in this 
study were based on defects that were reported and published for the National Birth Defects 
Prevention Network (NBDPN) Annual Report. The following broad organ systems or 
categories were included: central nervous system, ear/eye, cardiovascular, orofacial, 
gastrointestinal, genitourinary, musculoskeletal, and chromosomal defects (see Table 1 for 
specific defect breakdowns). Twenty of the 44 defects were not previously examined in the 
national studies on birth defects and race/ethnicity. If an infant was diagnosed with multiple 
birth defects, each occurrence of the defect was counted in each birth defect category.  
The NBDPN was used as guidance for the selection of birth defects to be included in 
this study because it is widely referred to by public health officials, researchers, and families 
for its high standards in birth defect surveillance.19 By combining data from several state and 
population-based surveillance systems, studies using the NBDPN data are able to have higher 
statistical power, which enables researchers to study rare birth defects and diverse 
6 
 
populations. Numerous publications on birth defects have been developed from the NBDPN 
data; therefore, using similar defects as those reported to the NBDPN allow for greater 
comparability with the results to existing work. 
 
Data Analysis 
Birth record data were obtained from the Texas DSHS Center for Health Statistics 
(CHS). Birth records are routinely linked to birth defect cases in the Texas BDR in order to 
gain maternal sociodemographic data for cases, such as maternal race/ethnicity and maternal 
age. Maternal race/ethnicity was categorized into the following categories: NH White, NH 
Asian, and any American Indian/Alaska Native. NH Blacks and Hispanics were excluded 
from this study. Race/ethnicity classification were based on vital records. Individuals were 
grouped by Hispanic ethnicity then by race. Additionally, NH Asians and AI/ANs who were 
misclassified in the “Other” race/ethnic category were corrected based on the “Other” race 
description field from the vital records. Because NH Asians and AI/ANs were the 
populations of interest, the data for NH Whites were not similarly corrected. As an aside, NH 
Asians and AI/ANs were not further stratified into specific subgroups due to the small 
population size. Records of mothers who were of multiple race/ethnicities or had that 
variable missing were excluded from the study. 
Birth defect prevalence were calculated by dividing cases of birth defects (of any 
pregnancy outcome) by the number of live births, in terms of cases per 10,000 live births. 
Live birth denominators are commonly used in birth defects epidemiology, even when non-
live cases are included in the numerator. Additionally, 95% confidence intervals (CIs) also 
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were calculated for each birth defect prevalence estimate. Birth defect prevalence was 
calculated for NH Whites alone, NH Asians alone, and any AI/AN alone. Poisson regression 
was used to calculate crude and adjusted prevalence ratios (aPRs) for each race/ethnic group, 
adjusting for maternal age (<20, 20-34, 35+ years). NH Whites served as the referent group. 
Crude prevalence ratios were not shown in the final results because the measures were 
similar to that of the aPRs. The 95% CIs were also provided with the aPRs following a 
Poisson distribution. These calculations were performed using SAS statistical software, 
version 9.4. 
 
Table 1:  Birth Defects Examined, Texas BDR, 1999-2015 
Central Nervous System 
Anencephalus 
Spina bifida without anencephalus 
Encephalocele 
Holoprosencephaly* 
Ear/Eye 
Anophthalmia/microphthalmia* 
Congenital cataract 
Anotia/microtia 
Cardiovascular 
Aortic valve stenosis 
Common truncus (truncus arteriosus) 
Transposition of great arteries (TGA) 
Ventricular septal defect 
Atrial septal defect* 
Atrioventricular septal defect (endocardial cushion defect) 
Pulmonary valve atresia and stenosis* 
Tricuspid valve atresia and stenosis* 
Ebstein's anomaly* 
Hypoplastic left heart syndrome* 
Coarctation of aorta 
Total anomalous pulmonary venous connection* 
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Single ventricle* 
Interrupted aortic arch* 
 
Orofacial 
Cleft palate alone 
Cleft lip alone 
Cleft lip with cleft palate 
Choanal atresia* 
Gastrointestinal 
Esophageal atresia/ tracheoesophageal fistula 
Rectal and large intestinal atresia/stenosis 
Biliary atresia* 
Small intestinal atresia/stenosis* 
Genitoururinary 
Renal agenesis/hypoplasia* 
Bladder exstrophy* 
Hypospadias 
Congenital posterior urethral valves* 
Musculoskeletal 
Gastroschisis 
Omphalocele 
Diaphragmatic hernia 
Limb deficiencies (reduction defects) 
Craniosynostosis* 
Clubfoot* 
Chromosomal 
Trisomy 13 
Trisomy 21 (Down syndrome) 
Trisomy 18 
Turner syndrome* 
Deletion 22q11.2* 
*defect was not previously examined in national studies15,16 
 
 
RESULTS 
This study included 75,960 cases of the selected birth defects that were either co-
occurring or isolated defects among NH Whites, NH Asians, and any AI/AN. There were 
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2,586,306 in the livebirth population, which accounts for approximately 40% of all livebirths 
in Texas from 1999 to 2015. Table 2 shows the prevalence and the 95% CIs for the 44 birth 
defects. This table shows prevalences for the total study population and for the 3 mutually 
exclusive race/ethnic groups: NH White, NH Asian, and any AI/AN. The least prevalent birth 
defects among NH Asians were bladder exstrophy, deletion 22q11.2, and common truncus. 
For both NH Asians and AI/ANs, the most prevalent defects were hypospadias, atrial septal 
defect, and ventricular septal defect. Among only AI/ANs, the least prevalent birth defects 
were trisomy 13, choanal atresia, and common truncus. However there were 3 defects with 0 
cases among the AI/AN population: Turner syndrome, interrupted aortic arch, and bladder 
exstrophy. Also note that approximately half of the prevalences among AI/ANs were based 
on 5 or less cases. 
 Table 3 displays the aPRs and 95% CIs for NH Asians and any AI/ANs, relative to 
NH Whites. Based on only statistically significant findings, NH Asians had a 50% or lower 
prevalence for spina bifida without anencephalus (aPR= 0.38; 95% CI= 0.25-0.54), 
craniosynostosis (aPR= 0.42; 95% CI= 0.39-0.46), and hypoplastic left heart syndrome 
(aPR= 0.46; 95% CI= 0.29-0.67), compared to NH Whites. Lower prevalence ratios were 
also noted for aortic valve stenosis (aPR= 0.54; 95% CI= 0.31-0.88), choanal atresia (aPR= 
0.54; 95% CI= 0.35-0.79), and esophageal atresia/tracheoesophageal fistula (aPR= 0.55; 95% 
CI= 0.31-0.89). Furthermore, NH Asians were found to have significantly higher prevalence 
rates for 3 defects: biliary atresia (aPR= 2.50, 95% CI= 2.06-3.01), total anomalous 
pulmonary venous connection (aPR= 1.36, 95% CI= 1.07-1.71), and anotia/microtia (aPR= 
1.19, 95% CI= 1.14-1.24). 
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 Among AI/ANs, only two defects had a statistically significantly lower aPR 
compared to NH Whites. These defects were hypoplastic left heart syndrome (aPR= 0.52, 
95% CI= 0.23-0.98) and hypospadias (aPR= 0.64, 95% CI= 0.45-0.88). Defects with a 
greater than 3-fold increased risk among AI/AN included biliary atresia (aPR= 4.63, 95% 
CI= 1.62-10.22), anotia/microtia (aPR= 3.27, 95% CI= 1.97-5.05), and holoprosencephaly 
(aPR= 3.05, 95% CI= 1.04-6.8). Additionally, elevated aPRs were observed for cleft lip with 
cleft palate (aPR= 2.68; 95% CI= 1.91-3.64), clubfoot (aPR= 1.48; 95% CI= 1.03-2.04), and 
esophageal atreasia/tracheoesophageal fistula (aPR= 1.36; 95% CI= 1.04-1.75). Although 
statistically significant, some of these results are based on small numbers, for example the 
high aPR seen for biliary atresia was based on only 4 cases in AI/ANs.
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Table 2:  Prevalence of Selected Birth Defects Among Maternal Racial/Ethnic Groups, Texas, 1999-2015 
 
 Total Non-Hispanic White Non-Hispanic Asian Any AI/AN 
Birth Defect n 
Prevalence  
(95% CI) 
n 
Prevalence  
(95% CI) 
n 
Prevalence  
(95% CI) 
n 
Prevalence  
(95% CI) 
Central Nervous System         
Anencephalus 496 1.92 (1.75-2.09) 448 1.94 (1.76-2.12) 43 1.67 (1.21-2.26) 5 3.29 (1.07-7.69) 
Spina bifida without anencephalus 827 3.2 (2.98-3.42) 788 3.40 (3.17-3.64) 33 1.28 (0.88-1.80) 6 3.95 (1.45-8.61) 
Encephalocele 184 0.71 (0.61-0.81) 161 0.70 (0.59-0.80) 21 0.82 (0.51-1.25) 2 1.32 (0.16-4.76) 
Holoprosencephaly 215 0.83 (0.72-0.94) 194 0.84 (0.72-0.96) 17 0.66 (0.39-1.06) 4 2.64 (0.72-6.75) 
Ear/Eye         
Anophthalmia/microphthalmia 720 2.78 (2.58-2.99) 659 2.85 (2.63-3.06) 53 2.06 (1.55-2.70) 8 5.27 (2.28-10.39) 
Congenital cataract 475 1.84 (1.67-2) 442 1.91 (1.73-2.09) 31 1.21 (0.82-1.71) 2 1.32 (0.16-4.76) 
Anotia/microtia 545 2.11 (1.93-2.28) 472 2.04 (1.86-2.22) 63 2.45 (1.89-3.14) 10 6.59 (3.16-12.12) 
Cardiovascular         
Common truncus (truncus arteriosus) 161 0.62 (0.53-0.72) 150 0.65 (0.54-0.75) 10 0.39 (0.19-0.72) 1 0.66 (0.02-3.67) 
Transposition of great arteries (TGA) 1250 4.83 (4.57-5.1) 1131 4.89 (4.6-5.17) 108 4.21 (3.41-5) 11 7.25 (3.62-12.97) 
Ventricular septal defect 13505 52.22 (51.34-53.1) 12220 52.8 (51.87-53.74) 1203 46.84 (44.2-49.49) 82 54.04 (42.98-67.07) 
Atrial septal defect 15749 60.89 (59.94-61.84) 14301 61.79 (60.78-62.81) 1357 52.84 (50.03-55.65) 91 59.97 (48.28-73.63) 
Atrioventricular septal defect  
     (endocardial cushion defect) 
1176 4.55 (4.29-4.81) 1093 4.72 (4.44-5) 77 3 (2.37-3.75) 6 3.95 (1.45-8.61) 
Pulmonary valve atresia and stenosis 2166 8.37 (8.02-8.73) 1986 8.58 (8.2-8.96) 163 6.35 (5.37-7.32) 17 11.2 (6.53-17.94) 
Tricuspid valve atresia and stenosis 437 1.69 (1.53-1.85) 387 1.67 (1.51-1.84) 48 1.87 (1.38-2.48) 2 1.32 (0.16-4.76) 
Ebstein's anomaly 179 0.69 (0.59-0.79) 159 0.69 (0.58-0.79) 18 0.7 (0.42-1.11) 2 1.32 (0.16-4.76) 
Aortic valve stenosis 681 2.63 (2.44-2.83) 638 2.76 (2.54-2.97) 39 1.52 (1.08-2.08) 4 2.64 (0.72-6.75) 
Hypoplastic left heart syndrome 625 2.42 (2.23-2.61) 593 2.56 (2.36-2.77) 30 1.17 (0.79-1.67) 2 1.32 (0.16-4.76) 
Coarctation of aorta 1419 5.49 (5.2-5.77) 1312 5.67 (5.36-5.98) 99 3.85 (3.13-4.69) 8 5.27 (2.28-10.39) 
Total anomalous pulmonary venous  314 1.21 (1.08-1.35) 270 1.17 (1.03-1.31) 41 1.6 (1.15-2.17) 3 1.98 (0.41-5.78) 
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     connection 
Single ventricle 195 0.75 (0.65-0.86) 179 0.77 (0.66-0.89) 14 0.55 (0.3-0.91) 2 1.32 (0.16-4.76) 
Interrupted aortic arch 147 0.57 (0.48-0.66) 136 0.59 (0.49-0.69) 11 0.43 (0.21-0.77) 0 - 
Orofacial Clefts         
Cleft palate alone 1702 6.58 (6.27-6.89) 1523 6.58 (6.25-6.91) 170 6.62 (5.62-7.61) 9 5.93 (2.71-11.26) 
Cleft lip alone 1008 3.9 (3.66-4.14) 920 3.98 (3.72-4.23) 81 3.15 (2.5-3.92) 7 4.61 (1.85-9.5) 
Cleft lip with cleft palate 1828 7.07 (6.74-7.39) 1624 7.02 (6.68-7.36) 175 6.81 (5.8-7.82) 29 19.11 (12.8-27.45) 
Gastrointestinal         
Choanal atresia 361 1.4 (1.25-1.54) 339 1.46 (1.31-1.62) 21 0.82 (0.51-1.25) 1 0.66 (0.02-3.67) 
Esophageal atresia/ tracheoesophageal  
     fistula 
604 2.34 (2.15-2.52) 564 2.44 (2.24-2.64) 35 1.36 (0.95-1.9) 5 3.29 (1.07-7.69) 
Rectal and large intestinal 
atresia/stenosis 
1293 5 (4.73-5.27) 1173 5.07 (4.78-5.36) 110 4.28 (3.48-5.08) 10 6.59 (3.16-12.12) 
Biliary atresia 174 0.67 (0.57-0.77) 133 0.57 (0.48-0.67) 37 1.44 (1.01-1.99) 4 2.64 (0.72-6.75) 
Small intestinal atresia/stenosis 788 3.05 (2.83-3.26) 730 3.15 (2.93-3.38) 54 2.1 (1.58-2.74) 4 2.64 (0.72-6.75) 
Genitourinary         
Renal agenesis/hypoplasia 1475 5.7 (5.41-5.99) 1330 5.75 (5.44-6.06) 134 5.22 (4.33-6.1) 11 7.25 (3.62-12.97) 
Bladder exstrophy 77 0.3 (0.23-0.37) 73 0.32 (0.25-0.4) 4 0.16 (0.04-0.4) 0 - 
Hypospadias 10639 80.18 (78.66-81.71) 9802 82.61 (80.97-84.24) 796 60.07 (55.90-64.25) 41 52.69 (37.81-71.47) 
Congenital posterior urethral valves 267 1.03 (0.91-1.16) 236 1.02 (0.89-1.15) 29 1.13 (0.76-1.62) 2 1.32 (0.16-4.76) 
Musculoskeletal         
Gastroschisis 1234 4.77 (4.51-5.04) 1164 5.03 (4.74-5.32) 59 2.3 (1.75-2.96) 11 7.25 (3.62-12.97) 
Omphalocele 549 2.12 (1.95-2.3) 499 2.16 (1.97-2.35) 44 1.71 (1.24-2.3) 6 3.95 (1.45-8.61) 
Diaphragmatic hernia 700 2.71 (2.51-2.91) 644 2.78 (2.57-3) 53 2.06 (1.55-2.7) 3 1.98 (0.41-5.78) 
Limb deficiencies (reduction defects) 1404 5.43 (5.14-5.71) 1298 5.61 (5.3-5.91) 87 3.39 (2.71-4.18) 19 12.52 (7.54-19.55) 
Craniosynostosis 1644 6.36 (6.05-6.66) 1560 6.74 (6.41-7.08) 76 2.96 (2.33-3.7) 8 5.27 (2.28-10.39) 
Clubfoot 4098 15.84 (15.36-16.33) 3815 16.48 (15.96-17.01) 246 9.58 (8.38-10.78) 37 24.38 (17.17-33.61) 
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Chromosomal         
Trisomy 13 304 1.18 (1.04-1.31) 264 1.14 (1-1.28) 39 1.52 (1.08-2.08) 1 0.66 (0.02-3.67) 
Trisomy 21 (Down syndrome) 3193 12.35 (11.92-12.77) 2891 12.49 (12.04-12.95) 287 11.18 (9.88-12.47) 15 9.88 (5.53-16.3) 
Trisomy 18 639 2.47 (2.28-2.66) 561 2.42 (2.22-2.62) 74 2.88 (2.26-3.62) 4 2.64 (0.72-6.75) 
Turner syndrome 274 2.18 (1.92-2.43) 255 2.26 (1.98-2.54) 19 1.53 (0.92-2.39) 0 - 
Deletion 22q11.2 115 0.44 (0.36-0.53) 103 0.45 (0.36-0.53) 10 0.39 (0.19-0.72) 2 1.32 (0.16-4.76) 
Note: AI/AN= American Indian/Alaska Native; CI= confidence interval 
Hypospadias restricted to males 
Turner syndrome restricted to females 
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Table 3. Adjusted Prevalence Ratios of Selected Birth Defects Among Maternal 
Racial/Ethnic Groups, Texas, 1999-2015 
 
  Non-Hispanic Asians Any AI/AN 
Birth Defect n 
Adjusted PR 
(95% CI) 
n 
Adjusted PR 
(95% CI) 
Central Nervous System     
Anencephalus 43 0.89 (0.47-1.53) 5 1.67 (0.55-3.77) 
Spina bifida without anencephalus 33 0.38 (0.25-0.54) 6 1.17 (0.6-2.01) 
Encephalocele 21 1.18 (0.84-1.62) 2 1.89 (0.76-3.81) 
Holoprosencephaly 17 0.83 (0.35-1.65) 4 3.05 (1.04-6.8) 
Ear/Eye     
Anophthalmia/microphthalmia 53 0.69 (0.48-0.97) 8 1.9 (0.8-3.75) 
Congenital cataract 31 0.63 (0.47-0.83) 2 0.69 (0.01-4.06) 
Anotia/microtia 63 1.19 (1.14-1.24) 10 3.27 (1.97-5.05) 
Cardiovascular     
Common truncus (truncus arteriosus) 10 0.58 (0.43-0.75) 1 1.05 (0.43-2.08) 
Transposition of great arteries (TGA) 108 0.83 (0.71-0.97) 11 1.52 (0.83-2.5) 
Ventricular septal defect 1203 0.86 (0.83-0.89) 82 1.04 (0.98-1.11) 
Atrial septal defect 1357 0.84 (0.76-0.92) 91 0.98 (0.81-1.17) 
Atrioventricular septal defect  
     (endocardial cushion defect) 
77 0.58 (0.3-1) 6 0.89 (0.47-1.5) 
Pulmonary valve atresia and stenosis 163 0.73 (0.56-0.94) 17 1.31 (1-1.69) 
Tricuspid valve atresia and stenosis 48 1.11 (0.8-1.5) 2 0.79 (0-7.24) 
Ebstein's anomaly 18 1 (0.77-1.29) 2 1.93 (0.71-4.11) 
Aortic valve stenosis 39 0.54 (0.31-0.88) 4 0.96 (0.46-1.75) 
Hypoplastic left heart syndrome 30 0.46 (0.29-0.67) 2 0.52 (0.23-0.98) 
Coarctation of aorta 99 0.66 (0.62-0.7) 8 0.94 (0.52-1.55) 
Total anomalous pulmonary venous  
     connection 
41 1.36 (1.07-1.71) 3 1.69 (0.64-3.56) 
Single ventricle 14 0.69 (0.36-1.18) 2 1.74 (0.87-3.07) 
Interrupted aortic arch 11 0.71 (0.59-0.85) 0 - 
Orofacial Clefts     
Cleft palate alone 170 1 (0.9-1.11) 9 0.9 (0.33-1.92) 
Cleft lip alone 81 0.81 (0.54-1.15) 7 1.15 (0.58-2.02) 
Cleft lip with cleft palate 175 0.99 (0.79-1.22) 29 2.68 (1.91-3.64) 
Gastrointestinal     
Choanal atresia 21 0.54 (0.35-0.79) 1 0.46 (0-4.57) 
Esophageal atresia/ tracheoesophageal fistula 35 0.55 (0.31-0.89) 5 1.36 (1.04-1.75) 
Rectal and large intestinal atresia/stenosis 110 0.84 (0.77-0.92) 10 1.3 (0.74-2.09) 
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Biliary atresia 37 2.5 (2.06-3.01) 4 4.63 (1.62-10.22) 
Small intestinal atresia/stenosis 54 0.67 (0.51-0.86) 4 0.82 (0.26-1.89) 
Genitourinary     
Renal agenesis/hypoplasia 134 0.9 (0.79-1.02) 11 1.27 (0.7-2.08) 
Bladder exstrophy 4 0.5 (0.19-1.04) 0 - 
Hypospadias 796 0.72 (0.67-0.76) 41 0.64 (0.42-0.93) 
Congenital posterior urethral valves 29 1.1 (0.89-1.33) 2 1.3 (0.19-4.25) 
Musculoskeletal     
Gastroschisis 59 0.63 (0.33-1.07) 11 1.19 (0.6-2.07) 
Omphalocele 44 0.76 (0.66-0.86) 6 1.88 (0.95-3.29) 
Diaphragmatic hernia 53 0.74 (0.54-1) 3 0.71 (0.04-3.2) 
Limb deficiencies (reduction defects) 87 0.62 (0.56-0.69) 19 2.18 (0.73-4.91) 
Craniosynostosis 76 0.42 (0.39-0.46) 8 0.8 (0.3-1.69) 
Clubfoot 246 0.58 (0.46-0.73) 37 1.48 (1.03-2.04) 
Chromosomal     
Trisomy 13 39 1.2 (0.94-1.51) 1 0.61 (0.21-1.35) 
Trisomy 21 (Down syndrome) 287 0.74 (0.69-0.78) 15 0.9 (0.55-1.36) 
Trisomy 18 74 0.96 (0.77-1.2) 4 1.25 (0.1-4.94) 
Turner syndrome 19 0.69 (0.51-0.90) 0 - 
Deletion 22q11.2 10 0.85 (0.49-1.38) 2 3.02 (0.26-12.01) 
Note: AI/AN= American Indian/Alaska Native; PR= prevalence ratio; CI= confidence interval 
Hypospadias restricted to males 
Turner syndrome restricted to females 
all aPRs are adjusted for maternal age; non-Hispanic Whites are the referent group 
 
 
DISCUSSION 
Overall, there were 34 statistically significant prevalence ratios. Among NH Asians, 
23 (52%) defects showed a lower aPR and 3 (7%) had a higher aPR out of the 44 defects 
studied. Furthermore, AI/ANs had 2 (5%) defects with lower aPRs and 6 (14%) with higher 
aPRs out of the 44 defects studied. Based on the 44 birth defects and 2 independent 
race/ethnic groups that were not NH White, by chance alone (p < 0.05) we would expect that 
4 prevalence ratios would have been statistically significant (i.e., 44 x 2 x 0.05). Yet we 
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observed 34 statistically significant prevalence ratios, which suggests that the results were 
not a chance finding. 
The aPRs calculated for AI/ANs were consistent with findings from the previous 
national studies examining this population.15,16 Specifically, anotia/microtia and cleft lip with 
cleft palate were both found to be significantly elevated among AI/ANs relative to NH 
Whites in the current study and previous national studies. Furthermore, for the NH Asian 
population, the previous national study found that the majority of birth defects studied (16 
out of 27, or 59%) had a significantly lower aPR. There were 11 defects that were found to 
be significant in both the previous and current studies, these defects include: spina bifida 
without anencephalus, anotia/microtia, common truncus, aortic valve stenosis, hypoplastic 
left heart syndrome, coarctation of the aorta, esophageal atresia, hypospadias, omphalocele, 
limb deficiencies, and trisomy 21. For defects that were significant in the previous study but 
were not in the current one, perhaps this is due to the smaller sample size and decreased 
power as analyses were conducted using data from only Texas rather pooled data from 12 
states. 
The lower prevalence rates observed for over half of the studied defects among the 
NH Asian population may be explained by various sociodemographic predictors for health. 
According to data from the National Vital Statistics System, compared to all U.S. mothers, 
NH Asian mothers were less likely to be teenagers and receive food prenatally via the 
Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and were 
more likely to be 30 years or older, be married, and have higher educational attainment.20 
These measures may be indicators of socioeconomic status, suggesting that NH Asian 
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mothers may have better access to prenatal care or are less exposed to risk factors that may 
cause birth defects. Furthermore, in the U.S. in 2016, 82.7% of NH Asian mothers were 
foreign-born.20 Therefore it is possible that the lower prevalence observed may be due to the 
“healthy immigrant effect”.21  Studies have found that foreign-born individuals tend to have 
better health outcomes compared to those who are U.S.-born. Immigrants are generally less 
likely to have cardiovascular disease, obesity, mental disorders, certain cancers, and low birth 
weight babies.21  
This study had several limitations. Because the analyses were conducted on rare 
outcomes (biliary atresia, holoprosencephaly, etc.) and among minority groups, some aPRs 
were calculated based on cell sizes with 5 cases or less. This was true for 20 defects for 
AI/ANs and 1 defect for NH Asians. This results in imprecise estimates, larger confidence 
intervals, and weaker associations. However, it is still important for this data to be shown 
because these two race/ethnic groups have been historically understudied due to small sample 
sizes. The small numbers also disabled us from adjusting for additional covariates and to 
further separate NH Asians into specific subgroups (e.g., Vietnamese, Chinese, etc.) and 
AI/ANs into specific tribes (e.g., Cherokee, Navajo, etc.).  
Despite the limitations, this study had several strengths. By using Texas data over 
many years, there was a large enough birth population to be able to make statistical 
inferences on the prevalence of selected birth defects for these lesser studied groups. 
Additionally, the current dataset included a more recent time period and a wider range of 
birth defects than the data used in the Canfield or Marengo study.15,16 The additional birth 
defects in the current study were:  holoprosencephaly, anophthalmia/microphthalmia, atrial 
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septal defect, pulmonary valve atresia and stenosis, tricuspid valve atresia and stenosis, 
Ebstein’s anomaly, hypoplastic left heart syndrome, total anomalous pulmonary venous 
connection, single ventricle, interrupted aortic arch, choanal atresia, biliary atresia, small 
intestinal atresia/stenosis, renal agenesis/hypoplasia, bladder exstrophy, congenital posterior 
urethral valves, craniosynostosis, clubfoot, Turner syndrome, and deletion 22q11.2.  
Although the population was smaller relative to national studies, the smaller size 
allowed the free text variable of race/ethnicity description to be further assessed, reclassified, 
and corrected. Specifically, we reclassified individuals in the NH and Hispanic “Other” 
race/ethnic group. Through these additional data cleaning steps, we identified 13 additional 
AI/AN cases, 306 additional AI/AN livebirths, 206 additional NH Asian cases, and 4,614 
additional NH Asian livebirths, adding power to analysis.  
 
CONCLUSION 
This study examined the association between understudied race/ethnicity and a wide 
range of birth defects within Texas using the most current data available. We found a number 
of birth defects with statistically significantly higher or lower prevalence ratios in NH Asians 
and AI/ANs, including some showing strong associations. Future research should explore 
additional covariates that may impact the prevalence of birth defects such as maternal parity, 
maternal and paternal education, paternal race/ethnicity, infant sex, smoking, and diabetes, 
where there are sufficient numbers. Additionally, NH Asians should be stratified into 
mothers’ specific countries of origin or nativity (U.S.-born vs. foreign-born) to determine 
impact of country of origin or nativity on prevalence. Additionally, where data are sufficient, 
19 
 
birth defects should be separated into isolated cases, vs. those co-occurring with other birth 
defects or chromosomal or syndromic conditions. Defects with higher prevalence among 
AI/ANs warrants additional research within larger populations.  
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